Hungary’s Széll Kálmán Plan can be implemented and the targeted reduction in drug subsidy expenditures can be achieved, reported Portfolio.hu quoting Mária Márki, head of the National Health Insurance Fund (OEP).
She added that the plans to reduce drug subsidy expenditures by HUF 83 billion in 2012 should be ready by the end of September. The state’s drug- and sick pay-related expenditures will be about HUF 30 billion smaller this year than in 2010, said Márki.
In an interview with local daily Népszabadság, she described Hungary’s drug subsidy system as perhaps “the most complex and most controversial system in the whole of Europe.” Yet, in her opinion there is no need for a back-up plan as the targets will be met.
The subsidies will be set based on the results achieved within the medicine in question. For example, with rare diseases that require expensive treatment, the government wants the producer of the drug to finance the first few treatments and the state would assume the costs only if the patient starts to get better, Márki added.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
